Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
-
LiveRamp Announces Results for First Quarter FY26
-
Assembly Biosciences Reports Interim Phase 1a Data from Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus
-
HilleVax Reports Second Quarter 2025 Financial Results
-
Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
-
Senseonics Holdings, Inc. Reports Second Quarter Financial Results
-
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
-
Crane NXT Reports Second Quarter 2025 Results
-
Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements
-
Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference
-
BBSI Reports Strong Second Quarter 2025 Financial Results
-
red violet Announces Second Quarter 2025 Financial Results
-
Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights
-
Veeco Reports Second Quarter 2025 Financial Results
-
Protagonist Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Viant to Participate in Upcoming Investor Conferences
-
Latham Group, Inc. to Participate at Upcoming Conferences in August 2025
-
Intelligent Protection Management Corp. to Report Second Quarter 2025 Financial Results on August 12, 2025
-
NHI Announces Increase for the Third Quarter 2025 Dividend
-
ATA Creativity Global Reports Q2 2025 Financial Results
-
TSS Reports Second Quarter 2025 Revenue of $44.0 Million, Up 262%
-
Insight to Present at Oppenheimer 28th Annual Technology, Internet & Communications Conference
-
Airbnb Announces Second Quarter 2025 Results
-
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
-
Upwork Reports Second Quarter 2025 Financial Results
-
Guadalupe Centers Celebrates the Grand Opening of Mixed-Income Housing for Teachers and Families in Kansas City, Missouri
-
Revolution Medicines Reports Second Quarter 2025 Financial Results and Update on Corporate Progress
-
Lyft Reports Record Q2 2025 Financial Results
-
NextNav Inc. Reports Second Quarter 2025 Results and Operational Highlights
-
Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook
-
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
-
Green Thumb Industries Reports Second Quarter 2025 Results
-
Outset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and Utilization
-
Bowman Reports Record Second Quarter 2025 Results
-
Power Integrations Reports Second-Quarter Financial Results
-
Transcat Reports Strong Fiscal First Quarter 2026 Financial Results with Double-Digit Revenue & Gross Profit Growth
-
Blue Bird Reports Fiscal 2025 Third Quarter Results; Beats Third Quarter Guidance With Record Results; Raising 2025 Guidance and Long-Term Outlook; $100M Share Buy-back Announced
-
Sonos Reports Third Quarter Fiscal 2025 Results
-
STAAR Surgical Reports Second Quarter 2025 Results
-
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Voyager Reports Second Quarter 2025 Financial and Operating Results
-
Sinclair Reports Second Quarter 2025 Financial Results
-
CSG Systems International Reports Second Quarter 2025 Results
-
Curaleaf Reports Second Quarter 2025 Results; Domestic Stabilization, Robust International Momentum
-
Travere Therapeutics Reports Second Quarter 2025 Financial Results
-
Alpha and Omega Semiconductor Reports Financial Results for Fiscal Fourth Quarter and Fiscal Year Ended June 30, 2025
-
CareDx Announces Second Quarter 2025 Financial Results
-
Xencor Reports Second Quarter 2025 Financial Results
-
Neurocrine Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference
-
Keros Therapeutics Reports Second Quarter 2025 Financial Results
